Nel ASA: Surging Orders Meet a Shrunken Revenue Base

Nel ASA's third-quarter 2026 report card presents investors with a split-screen picture. Orders are flooding in, yet the money actually booked from customers has contracted sharply — and that divergence, rather than any single headline number, is what now defines the investment case.

Revenue from customer contracts fell 63% year on year to NOK 112 million in the quarter, according to the company. That steep drop sets the floor from which any recovery must be measured.

Against that backdrop, order intake jumped 339% to NOK 253 million, while the order backlog climbed 34% year on year to reach NOK 1,314 million. The figures point to a firmer demand base — but they are not revenue already earned, nor evidence of profit. For shareholders, the direction of incoming orders matters less than whether those orders can be converted into deliveries and, eventually, into results.

The pressure on the bottom line remains plain. Nel reported EBITDA of NOK -93 million and a net loss of NOK -141 million. More contractually secured business is a welcome signal; it does not, on its own, amount to an economic stabilization. The next operational updates will have to demonstrate that the stronger order book pays off beyond the order statistics.

A Concrete US Contract With a Date Attached

One development lends the bullish case something tangible. Nel Hydrogen US, the group's American subsidiary, secured an order roughly a week ago from an unnamed global technology company headquartered in the United States. The contract covers several containerized PEM electrolysers along with associated services, carries a value of about USD 12 million, and is scheduled for delivery in 2027.

That gives investors a confirmed purchase with a timeline — a meaningful distinction from a mere review of possible projects. Should Nel execute such orders on schedule and keep winning further binding business, the recovery thesis would gain credibility. A single contract, however, does not yet prove that trend.

A second potential avenue comes from the collaboration with Rheinmetall. The letter of intent signed about a week ago covers decentralized renewable synthetic fuel production for defense and critical infrastructure. Any concrete orders emerging from that review would add another business perspective — an extension of the bull case, not its already-secured foundation.

Why the Rheinmetall Deal Isn't Revenue

The counterargument carries real weight. The Rheinmetall agreement, being non-binding, provides first for examining joint opportunities, including feasibility questions and possible pilot projects. No confirmed project order is attached to it. Treating the potential cooperation as future revenue would therefore be a risky leap: there is a material difference between a joint review and a binding purchase order, and even the execution of a pilot project is not yet confirmed by the letter of intent.

Meanwhile, the weak top line limits how much weight the higher order intake can bear. If improved bookings fail to translate into better operating performance, the recovery story stays vulnerable. Fresh project opportunities would not offset that weakness — they would mainly create expectations, while the losses are already real.

What Investors Should Track Next

The key metric for coming business updates remains revenue from customer contracts. A renewed rise would show that the stronger order position is flowing through to the business; growth in the backlog alone would leave the decisive test unmet. Investors would be wise to hold that distinction even when further positive order announcements arrive.

For a durable recovery, both sides would need to converge: the existing backlog would have to convert into deliveries and services, while new orders sustain the broader trajectory. A large backlog by itself answers neither the question of conversion speed nor that of order quality. And even a revenue revival would not automatically dispel all doubts — whether losses shrink alongside would matter just as much. Rising sales paired with persistently weak earnings could cap the recovery thesis, while a fresh revenue decline would show that the better order situation is not yet cushioning the operational weakness.

The near-term anchor is the US delivery expected in 2027. A binding project emerging from the Rheinmetall review could serve as an additional catalyst, though the letter of intent does not confirm that step. The choice for investors is thus clearly framed: backing a Nel turnaround means betting on the economic execution of secured business, while those demanding greater certainty will want further operational proof. What counts is not the number of conceivable projects but the durability of what actually materializes.